Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) - Wikidata - awgldk - TriplyDB

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

http://www.wikidata.org/entity/Q28366662

about

Advanced glycation end-products induce calpain-mediated degradation of ezrin Does accumulation of advanced glycation end products contribute to the aging phenotype?Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities Advanced glycation end products and diabetic complications High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis AGEs in human lens capsule promote the TGFβ2-mediated EMT of lens epithelial cells: implications for age-associated fibrosis Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway Effects of Chinese Medicine Tong xinluo on Diabetic Nephropathy via Inhibiting TGF- β 1-Induced Epithelial-to-Mesenchymal Transition.Effect of the age cross-link breaker alagebrium on anterior segment physiology, morphology, and ocular age and rage.Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB.AGEs decrease insulin synthesis in pancreatic β-cell by repressing Pdx-1 protein expression at the post-translational level.E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy Diet-induced obesity model: abnormal oocytes and persistent growth abnormalities in the offspring.Renal fibrosis.miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2.IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis.A glimpse of matrix metalloproteinases in diabetic nephropathy.High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.Role of tissue stroma in cancer cell invasion.Advanced glycation end products are direct modulators of β-cell function.17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice Novel pharmacological treatments for heart failure.Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis

P2860

Q24293645-789C77B6-B1BE-44EB-8A64-47FBD2699D85 Q24632710-1CFF734C-702F-4BD6-BEBF-0D370EF89BCC Q24794548-CE19B4AB-808D-4ECA-A070-62B1FB855E30 Q26782283-7FDF7017-C2A5-4D2B-B3E2-0A422E39264B Q26825697-747F5067-74CD-48E6-A3F1-F905A89003EB Q27687501-55FDFADB-CD9C-48C8-8F57-C91C7E927394 Q28066302-2BAE0845-6DC0-4E4B-B6D6-A11EAD05609C Q28269990-BA7197FC-5A6D-4637-85B6-9AB16DDEE422 Q28507626-E936423B-21EA-46E2-BD45-C327C238130C Q28833644-F08A68A0-0B36-41E3-8CAF-DFE1E733BBD0 Q29346955-A4B404B4-927A-48A2-B0A0-046B6ED6F538 Q30445160-1FB3AA52-6254-4E19-878E-A6780EA2DE80 Q33594088-B04E1EF3-4F4A-4DC5-A948-AEABB32F3A97 Q33623472-9D09A865-7C3C-48D2-BEAE-3809B6D62133 Q33637693-81A0D5AF-412F-4636-A529-75BC3CE157CD Q33711031-EED8297D-643D-4A66-BF50-608D40A43558 Q33711306-F6F31A4C-E425-4EE3-8C9E-E840CF9DAD96 Q33727178-09AB6B75-2256-406C-AD4F-5170474E0EAD Q33727834-4AAAC9EA-72F5-4293-9451-A52569BCB5CA Q33786872-6C49E040-1CDE-4F3B-AA46-F923DD53D8CC Q33811066-031D725B-07E0-4A5A-8929-32AC240AF328 Q33886522-C5D761D4-74EB-4DFF-BDCC-CFE2403AC24A Q33930316-D07B516E-362C-488F-B9A5-1C57A6897470 Q34067504-019152CC-CF0E-40A1-AD45-E1E7B7859E25 Q34132433-CB84CF5E-B5AC-4CA3-81BB-7CC8D69BEF9C Q34417331-DEF8B883-D2C5-431C-8CF5-0159FA680002 Q34448719-A9F54EBA-7935-42DB-8EEC-C0B5E6413E8D Q34501850-397845B3-D1B7-4B1A-BEED-C0CEB9EF3E7B Q34623871-D56BB796-3F3F-47B0-BD5F-4C14C0CBF2B2 Q34790437-5DE15793-08C8-4E6D-9A53-6C9217339273 Q34796034-3A34888B-30EF-4130-8E1A-7A0F6F7FB872 Q34987778-8AD162D9-3F20-4DBE-A078-1B4FE12E754F Q35085117-C9D9B555-897B-4D6B-8862-35AC708F21CF Q35170428-CBB4232F-D4E5-452D-8D6D-B44241E205AA Q35227180-593D3D12-F966-49E3-8AEA-574BA04BF756 Q35230894-C74CEB0C-821F-42DB-B59A-FB063BAFBD2E Q35255473-B663463A-D902-4B5E-ADCA-7296A3B90EC1 Q35549187-F0A05CEC-E542-4A81-B69E-883C48F1EC9E Q35570949-C47069A3-DB1E-4288-9996-E4E063879107 Q35715738-EE56F0F4-C3F3-4523-970E-91391187B175

P2860

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

http://www.wikidata.org/entity/Q28366662

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Advanced glycation end product ...... glycation end products (RAGE)

@ast

Advanced glycation end product ...... glycation end products (RAGE)

@en

Advanced glycation end product ...... glycation end products (RAGE)

@nl

type

label

Advanced glycation end product ...... glycation end products (RAGE)

@ast

Advanced glycation end product ...... glycation end products (RAGE)

@en

Advanced glycation end product ...... glycation end products (RAGE)

@nl

prefLabel

Advanced glycation end product ...... glycation end products (RAGE)

@ast

Advanced glycation end product ...... glycation end products (RAGE)

@en

Advanced glycation end product ...... glycation end products (RAGE)

@nl

P1433

Q28366662-9FC78C01-FEA2-4DC0-A3B9-64D29FA7C0FC

P1476

Q28366662-68A437C7-86C8-4A24-AC90-74A1F3AE035F

P2093

Q28366662-12963431-DA5A-491E-956C-EABD83786594

Q28366662-38AF550D-E852-434F-B7D3-E8A612C89769

Q28366662-521B3AA2-908F-4A95-B21E-47A579AAD006

Q28366662-672F69DB-EB51-4889-9522-FAB7C3FFB402

Q28366662-8FF4DE0F-27F3-405E-9905-96AA8B7FDC79

Q28366662-A068368F-39BF-405E-93AA-F4F9CD67BC6A

Q28366662-CF601D2E-EDC2-4ACE-98F3-E6A52E7715B5

Q28366662-DB01EBAC-9997-49CB-91CE-F55498D2FA62

Q28366662-DE72AB6B-8924-4C63-BA92-FBE7122C57FC

P2860

Q28366662-0905B15E-9392-42FB-81A1-1646CAAF2C4B

Q28366662-0A30921D-8239-4C82-A806-A1417783E647

Q28366662-0C66B959-0D2F-4420-AF89-1C925D49CAFE

Q28366662-0D45CCFD-436C-4838-894F-80522737E98B

Q28366662-116DB008-FEFE-46B5-900F-79E829303221

Q28366662-1D9D070B-3E2A-48F8-BA61-121881F45A1C

Q28366662-2326E60D-385A-41A9-94B6-61C37B922DEB

Q28366662-28853A70-573C-4AD2-A688-295E4D8D16B0

Q28366662-2AF520FF-8A2E-40D3-A1E3-605C9424F8FB

Q28366662-307609D9-BDD9-4594-9AF1-364CC4DB67F4

P304

Q28366662-F2F3101D-E34C-4967-9E14-8CCC3D2C664A

P31

Q28366662-65B6C76C-FA33-4E02-AD24-7C82AB1FECBB

P3181

Q28366662-8A6517D4-A4F1-4352-BC63-350705C40AF6

P356

Q28366662-3777745D-A3CD-46D9-A572-49BA4C25131B

P407

Q28366662-9C7B111B-6048-4C1F-B5E4-9C7CA64A139D

P433

Q28366662-86937079-E5EB-4B27-8348-673FCDE39212

P478

Q28366662-C3463762-B3C8-4D59-BF3C-B3827F59CD1D

P50

Q28366662-0D40AE30-98F7-46F6-B96F-F3484DF80F8E

P577

Q28366662-D9F227E7-82A6-4734-BCE7-412E63B01A9A

P698

Q28366662-DA729C2F-4139-4999-AC9A-85C7840131B2

P932

Q28366662-BBBD9FED-5AD2-48A2-A1A6-D45BD43C9BD4

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Advanced glycation end product ...... glycation end products (RAGE)

@en

P2093

A McRobert

http://www.w3.org/2001/XMLSchema#string

D Nikolic-Paterson

http://www.w3.org/2001/XMLSchema#string

G Jerums

http://www.w3.org/2001/XMLSchema#string

L A Bach

http://www.w3.org/2001/XMLSchema#string

M D Oldfield

http://www.w3.org/2001/XMLSchema#string

M E Cooper

http://www.w3.org/2001/XMLSchema#string

R C Atkins

http://www.w3.org/2001/XMLSchema#string

T Osicka

http://www.w3.org/2001/XMLSchema#string

V Thallas

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a reexamination.

Renoprotective effects of a novel inhibitor of advanced glycation.

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.

P304

1853-1863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2661766

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI11951

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Josephine M. Forbes

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11748269

http://www.w3.org/2001/XMLSchema#string

P932

209461

http://www.w3.org/2001/XMLSchema#string